BTMD Stock — biote Corp

biote Corp (BTMD)

Updated October 16, 2026.

BTMD is a Stock. Total return is -89.2% over the past 5.5 years, 186.0 points behind SPY at 96.8%.

biote Corp operates in the hormone optimization space, training physicians and nurse practitioners in bioidentical hormone replacement pellet therapy and providing a comprehensive practice-building platform that includes certification, practice management software, inventory management tools, and marketing support, along with related dietary supplements and pellet insertion kits. The company's distribution status is not currently known. This business appeals to investors seeking exposure to the healthcare services and wellness sectors.

BTMD performance versus SPY

Price and return data through 2026-10-16.

Total return is -89.2% over the past 5.5 years, 186.0 points behind SPY at 96.8%. Over the past year its total return — price change plus distributions reinvested — is -62.6%. Its deepest 1-year drawdown was 67.4%.

BTMD key facts

Asset type

Stock

Asset class

Equity

Inception date

04/28/2021

Distribution frequency

None

Last close

$1.08 (as of 2026-10-16)

Market cap

$31,115,184

Average volume

41588.0

Beta

1.69

Payout ratio

0.0%

P/E ratio

7.75

Forward P/E

5.2002

EPS

$0.14

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

BTMD risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 67.4%.

Who may consider BTMD — and who may not

It is a weaker fit for investors who need monthly cash flow (BTMD does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on BTMD

• All tickers starting with B

Tagged: Healthcare.

Frequently asked questions